Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement.
Screening auf mit rheumatoider Arthritis assoziierte interstitielle Lungenerkrankung – Delphi-basiertes Konsensus-Statement.
Antifibrotic agents
Autoimmune diseases
Fibrosis
Mass screening
Risk factors
Journal
Zeitschrift fur Rheumatologie
ISSN: 1435-1250
Titre abrégé: Z Rheumatol
Pays: Germany
ID NLM: 0414162
Informations de publication
Date de publication:
19 Jan 2024
19 Jan 2024
Historique:
accepted:
27
11
2023
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
19
1
2024
Statut:
aheadofprint
Résumé
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients. After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached. A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening. HINTERGRUND: Die mit der rheumatoiden Arthritis (RA) assoziierte interstitielle Lungenerkrankung (RA-ILD) ist ein wesentlicher Faktor für die erhöhte Mortalität der Erkrankung. Die frühzeitige Diagnose ist für die Prognose bestimmend und liegt im Aufgabenbereich der behandelnden Spezialist:innen. Dennoch gibt es bislang keine internationalen Guidelines oder Screening-Empfehlungen für die RA-ILD. Um ein Delphi-Konsensus-Statement zu erstellen, wurde eine Expert:innengruppe aus den Fachgebieten Pneumologie, Rheumatologie und Radiologie gebildet. Nach Analyse der aktuell verfügbaren Literatur erfolgten Fragerunden und Diskussionen, basierend auf der modifizierten Delphi-Methode in Kombination mit der nominalen Gruppenmethode. Unter Berücksichtigung von klinischen Zeichen, Symptomen und Risikofaktoren wurde ein Algorithmus zur frühzeitigen Detektion einer ILD bei RA-Patient:innen ausgearbeitet. Darüber hinaus wurden Empfehlungen zu den Screening-Methoden sowie zum Follow-up bei RA-ILD formuliert.
Autres résumés
Type: Publisher
(ger)
HINTERGRUND: Die mit der rheumatoiden Arthritis (RA) assoziierte interstitielle Lungenerkrankung (RA-ILD) ist ein wesentlicher Faktor für die erhöhte Mortalität der Erkrankung. Die frühzeitige Diagnose ist für die Prognose bestimmend und liegt im Aufgabenbereich der behandelnden Spezialist:innen. Dennoch gibt es bislang keine internationalen Guidelines oder Screening-Empfehlungen für die RA-ILD.
Identifiants
pubmed: 38240817
doi: 10.1007/s00393-023-01464-w
pii: 10.1007/s00393-023-01464-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Løkke A, Bendstrup E et al (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700–1706
doi: 10.1136/annrheumdis-2017-211138
pubmed: 28611082
Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6):1583–1591
doi: 10.1002/art.27405
pubmed: 20155830
pmcid: 4028137
Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J et al (2011) Rheumatoid arthritis–interstitial lung disease–associated mortality. Am J Respir Crit Care Med 183(3):372–378
doi: 10.1164/rccm.201004-0622OC
pubmed: 20851924
pmcid: 5450769
Farquhar H, Vassallo R, Edwards AL, Matteson EL (eds) (2019) Pulmonary complications of rheumatoid arthritis. Seminars in respiratory and critical care medicine. Thieme
Yunt ZX, Solomon JJ (2015) Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am 41(2):225–236
doi: 10.1016/j.rdc.2014.12.004
pubmed: 25836639
pmcid: 4415514
Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J et al (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 49(8):1483–1489
doi: 10.1093/rheumatology/keq035
pubmed: 20223814
Duarte AC, Porter JC, Leandro MJ (2019) The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment. Rheumatology 58(11):2031–2038
doi: 10.1093/rheumatology/kez177
pubmed: 31089697
Kreuter M, Behr J, Bonella F, Costabel U, Gerber A, Hamer OW et al (2023) S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter. Pneumologie (269–302)
Caro F, Donati P, Ruiz R, Auteri S, Fassola L, Fernández M et al (2022) Baseline characteristics and survival of progressive fibrosing interstitial lung disease in rheumatoid arthritis. A single center retrospective study. Eur Respiratory Soc
Bilgici A, Ulusoy H, Kuru O, Celenk C, Ünsal M, Danacı M (2005) Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 25:429–435
doi: 10.1007/s00296-004-0472-y
pubmed: 16133582
Mori S, Cho I, Koga Y, Sugimoto M (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35(8):1513–1521
pubmed: 18597412
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SL, Inoue Y et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718–1727
doi: 10.1056/NEJMoa1908681
pubmed: 31566307
Narváez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G et al (2023) Screening criteria for interstitial lung disease associated to rheumatoid arthritis: expert proposal based on Delphi methodology. Reumatol Clin 19(2):74–81 ((English Edition))
doi: 10.1016/j.reuma.2021.12.006
pubmed: 35753951
Radić M, Novak S, Barešić M, Hećimović A, Perković D, Tekavec-Trkanjec J et al (2022) Delphi-based consensus on interstitial lung disease screening in patients with connective tissue diseases (croatian national-based study). Biomedicines 10(12):3291
doi: 10.3390/biomedicines10123291
pubmed: 36552047
pmcid: 9775485
Green B, Jones M, Hughes D, Williams A (1999) Applying the Delphi technique in a study of GPs’ information requirements. Health Soc Care Community 7(3):198–205
doi: 10.1046/j.1365-2524.1999.00176.x
pubmed: 11560634
Van de Ven AH, Delbecq AL (1972) The nominal group as a research instrument for exploratory health studies. Am J Public Health 62(3):337–342
doi: 10.2105/AJPH.62.3.337
pubmed: 5011164
pmcid: 1530096
Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD et al (2013) Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med 107(8):1247–1252
doi: 10.1016/j.rmed.2013.05.002
pubmed: 23791462
Cottin V, Cordier J‑F (2012) Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respiratory Soc (p. 519–21)
Gochuico BR, Avila NA, Chow CK, Novero LJ, Wu H‑P, Ren P et al (2008) Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 168(2):159–166
doi: 10.1001/archinternmed.2007.59
pubmed: 18227362
Furini F, Carnevale A, Casoni GL, Guerrini G, Cavagna L, Govoni M et al (2019) The role of the multidisciplinary evaluation of interstitial lung diseases: systematic literature review of the current evidence and future perspectives. Front Med 6:246
doi: 10.3389/fmed.2019.00246
Yamakawa H, Sato S, Tsumiyama E, Nishizawa T, Kawabe R, Oba T et al (2019) Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria. J Thorac Dis 11(12):5247
doi: 10.21037/jtd.2019.11.73
pubmed: 32030242
pmcid: 6987998
Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B et al (2021) Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J Rheumatol 48(5):656–663
doi: 10.3899/jrheum.200863
pubmed: 33191286
Kakutani T, Hashimoto A, Tominaga A, Kodama K, Nogi S, Tsuno H et al (2020) Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease. Mod Rheumatol 30(3):458–464
doi: 10.1080/14397595.2019.1621462
pubmed: 31116052
O’Dwyer DN, Armstrong ME, Cooke G, Dodd JD, Veale DJ, Donnelly SC (2013) Rheumatoid arthritis (RA) associated interstitial lung disease (ILD). Eur J Intern Med 24(7):597–603
doi: 10.1016/j.ejim.2013.07.004
pubmed: 23916467
Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC et al (2015) Detection of rheumatoid arthritis–interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med 191(12):1403–1412
doi: 10.1164/rccm.201411-1950OC
pubmed: 25822095
pmcid: 4476561
Restrepo JF, Del Rincón I, Battafarano DF, Haas RW, Doria M, Escalante A (2015) Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol 34:1529–1536
doi: 10.1007/s10067-015-3025-8
pubmed: 26255186
Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM et al (2019) Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis–associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol 71(9):1472–1482
doi: 10.1002/art.40904
pubmed: 30951251
pmcid: 6716994
Natalini JG, Baker JF, Singh N, Mahajan TD, Roul P, Thiele GM et al (2021) Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of US veterans. Ann Am Thorac Soc 18(4):598–605
doi: 10.1513/AnnalsATS.202006-590OC
pubmed: 33026891
pmcid: 8009007
Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36:817–823
doi: 10.1007/s10067-017-3561-5
pubmed: 28191607
Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J et al (2022) A risk score to detect subclinical rheumatoid arthritis–associated interstitial lung disease. Arthritis Rheumatol 74(11):1755–1765
doi: 10.1002/art.42162
pubmed: 35583934
pmcid: 9828082
Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN et al (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study. Rheumatology 53(9):1676–1682
doi: 10.1093/rheumatology/keu165
pubmed: 24758887
Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM III, Myasoedova E et al (2022) Incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis–associated interstitial lung disease: a population-based cohort. Arthritis Care Res 74(12):2042–2049
doi: 10.1002/acr.24856
Juge P‑A, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S et al (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379(23):2209–2219
doi: 10.1056/NEJMoa1801562
pubmed: 30345907
pmcid: 6371965
Juge P‑A, Borie R, Kannengiesser C, Gazal S, Revy P, Wemeau-Stervinou L et al (2017) Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J (49(5))
Garrote-Corral S, Silva-Fernández L, Seoane-Mato D, Guerra-Rodríguez M, Aburto M, Castañeda S et al (2022) Screening of interstitial lung disease in patients with rheumatoid arthritis: a systematic review. Reumatol Clin 18(10):587–596 ((English Edition))
doi: 10.1016/j.reuma.2021.07.008
pubmed: 34776393
Portal JAR, García NB, del Campo Fontecha PD, Valenzuela C, Ortiz AM, Nieto MA et al (2022) SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: epidemiology, risk factors and prognosis. Reumatol Clin 18(8):443–452 ((English Edition))
Delle Sedie A, Carli L, Cioffi E, Bombardieri S, Riente L (2012) The promising role of lung ultrasound in systemic sclerosis. Clin Rheumatol 31:1537–1541
doi: 10.1007/s10067-012-2030-4
pubmed: 22843171
Grohs M, Moazedi-Fuerst F, Flick H, Hackner K, Haidmayer A, Handzhiev S et al (2022) Value of CT and transthoracic lung ultrasound in patients with systemic sclerosis: joint statement of the ÖRG/ÖGP/ÖGR/ÖGUM. Z Rheumatol 81(7):610–618
doi: 10.1007/s00393-022-01206-4
pubmed: 35513537
pmcid: 9468076
Moazedi-Fuerst F, Kielhauser S, Scheidl S, Tripolt N, Lutfi A, Yazdani-Biuki B et al (2014) Ultrasound screening for interstitial lung disease in rheumatoid arthritis. Clin Exp Rheumatol 32(2):199–203
pubmed: 24642277
Mathis G, Horn R, Morf S, Prosch H, Rovida S, Soldati G et al (2021) WFUMB position paper on reverberation artefacts in lung ultrasound: B‑lines or comet-tails? Med Ultrason 23(1):70–73
doi: 10.11152/mu-2944
pubmed: 33621275
Brenner DJ, Hall EJ (2007) Computed tomography—an increasing source of radiation exposure. N Engl J Med 357(22):2277–2284
doi: 10.1056/NEJMra072149
pubmed: 18046031
Joo YB, Ahn SM, Bang S‑Y, Park Y, Hong SJ, Lee Y et al (2022) MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations. RMD Open 8(2):e2790
doi: 10.1136/rmdopen-2022-002790
pubmed: 36581384
pmcid: 9806030